Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prospective observational study of tofogliflozin in patients with type 2 diabetes
jRCT1090220212Completed
- Sponsor
- Nagoya Medical Association
- Start
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of tofogliflozin in type 2 diabetes mellitus (T2DM), sponsored by Nagoya Medical Association. Primary endpoints: Change in HbA1c level from baseline to 12 months and Number of adverse events. Started Apr 2015; status: completed.
02
Drugs
tofogliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on jRCT1090220212.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1090220212.